| 序号 | 专利名 | 申请号 | 申请日 | 公开（公告）号 | 公开（公告）日 | 发明人 |
|---|---|---|---|---|---|---|
| 121 | COMPOSITION FOR USE IN STIMULATING THE INTESTINAL FLORA IN INFANTS DELIVERED BY CAESAREAN SECTION | EP17205437.1 | 2006-10-20 | EP3326634A3 | 2018-07-18 | Boehm, Günther; Knol, Jan; Stahl, Bernd |
The present invention relates to compositions to be administered to infants delivered via caesarian section and in particular to the use of a) at least two different microorganisms; or b) at least one microorganism and at least one indigestible oligosaccharide; or c) at least two, preferably three, different Bifidobacteria species, subspecies or strains for the manufacture of a composition for enteral administration to an infant delivered via caesarean section. Thereby it is possible to stimulate the healthy development of the intestinal flora of said infants. |
||||||
| 122 | METHOD OF IMPROVING SKILLS WITH A COMPOSITION COMPRISING NON-DIGESTIBLE SACCHARIDE | EP07747346.0 | 2007-03-13 | EP2117355B1 | 2017-04-26 | STAHL, Bernd; KNOL, Jan |
| The present invention concerns a therapy aimed at language and/or social skills in infants through administration of components stimulating the development of a healthy intestinal flora. | ||||||
| 123 | METHOD FOR STIMULATING INTESTINAL BARRIER INTEGRITY AFTER NON-NATURAL BIRTH | EP15181073.6 | 2006-10-06 | EP2984943A1 | 2016-02-17 | Schmitt, Joachim; Boehm, Günther; Beermann, Christopher |
The present invention relates to methods for feeding and stimulating the health of infants delivered via caesarean section comprising administering long chain polyunsaturated fatty acids and/or nucleotides. |
||||||
| 124 | PREBIOTIC COMPOSITIONS | EP03785796.8 | 2003-12-11 | EP1571923B1 | 2014-01-22 | GIBSON, Glenn R.; KOLIDA, Sofia |
| The present invention concerns nutritional compositions comprising oligosaccharides for controlling inflammatory bowel disease and related disorders, such as diarrhea and constipation. | ||||||
| 125 | Method for stimulating the intestinal flora in infants delivered by caesarean section | EP09011197.2 | 2006-10-20 | EP2140771B1 | 2013-12-11 | Boehm, Günther; Stahl, Bernd; Knol, Jan |
| The present invention relates to methods for feeding and to compositions to be adminis | ||||||
| 126 | LOW CALORIE INFANT FORMULA WITH IMPROVED PHYSICAL ATTRIBUTES | EP11809043.0 | 2011-12-21 | EP2658398A1 | 2013-11-06 | CLINGER, Christine L.; MARRIAGE, Barbara J. |
| The present disclosure is directed to low calorie infant formulas, and in particular, low calorie infant formulas that have a low buffering capacity, exhibit an increased rate of protein hydrolysis and digestion, and have an improved tolerance, as compared to full calorie infant formulas. Also disclosed are low calorie liquid infant formulas that have a reduced (i.e., "low") micronutrient content on a per volume basis, and exhibit an overall improvement in the physical properties of the formula, as compared to low calorie liquid infant formulas having a higher micronutrient content. | ||||||
| 127 | Method for stimulating intestinal barrier integrity after non-natural birth | EP11178047.4 | 2006-10-06 | EP2407036A1 | 2012-01-18 | Schmitt, Joachim; Boehm, Günther; Beermann, Christopher |
The present invention relates to methods for feeding and stimulating the health of infants delivered via caesarean section comprising administering long chain polyunsaturated fatty acids and/or nucleotides |
||||||
| 128 | PROCESS FOR ISOLATING SIALIC ACID CONTAINING OLIGOSACCHARIDES, AND THE COMPOSITIONS CONTAINING SIALIC ACID CONTAINING OLIGOSACCHARIDES OBTAINABLE THEREBY | EP09720678.3 | 2009-03-13 | EP2268162A2 | 2011-01-05 | BONTE, Alfred Willy; KLARENBEEK, Gijsbertus; BECKER, Marcus Johannes Aloysius |
| The invention relates to a process for isolating sialic acid containing oligosaccharides and in particular sialyllactose from a milk stream and especially from a whey stream. The process yields a product having a high content of sialyllactose and a low content of phosphorus compounds. This product is highly suitable to be included in infant foods. | ||||||
| 129 | Method for stimulating intestinal barrier integrity after birth by caesarean section | EP09161674.8 | 2006-10-06 | EP2105055A1 | 2009-09-30 | Schmitt, Joachim; Boehm, Günther; Beermann, Christopher |
The present invention relates to methods for feeding and stimulating the health of infants delivered via caesarean section comprising administering long chain polyunsaturated fatty acids and/or nucleotides |
||||||
| 130 | METHOD FOR STIMULATING INTESTINAL BARRIER INTEGRITY AFTER NON-NATURAL BIRTH | EP06799538.1 | 2006-10-06 | EP1940247B1 | 2009-06-03 | SCHMITT, Joachim; BOEHM, Gunther; BEERMANN, Christopher |
| The present invention relates to methods for feeding and to compositions to be adminis | ||||||
| 131 | METHOD FOR TREATING AND/OR PREVENTING INFECTIONS IN INFANTS DELIVERED VIA CAESAREAN SECTION | EP06799536.5 | 2006-10-06 | EP1940245A1 | 2008-07-09 | SCHMITT, Joachim; STAHL, Bernd; KNOL, Jan |
| The present invention relates to methods for feeding and to compositions to be adminis | ||||||
| 132 | NUTRITIONAL FORMULATION CONTAINING PREBIOTIC SUBSTANCES | EP01910704.4 | 2001-02-15 | EP1255449B1 | 2007-03-28 | WILSON, Jeffrey, L. |
| A nutritional composition is provided which comprises oligofructose and sialyllactose. | ||||||
| 133 | USE OF INDIGESTIBLE OLIGOSACCHARIDES TO TREAT AND PREVENT OTITIS MEDIA IN HUMANS | EP96922652.1 | 1996-07-02 | EP0837686B1 | 2002-10-09 | DOHNALEK, Margaret, Ione, Halpin; OSTROM, Karin, Margaret; HILTY, Milo, Duane |
| A method is provided for reducing the incidence of otitis media in infants and young children by enterally administering indigestible oligosaccharides. More specifically, the present invention relates to a method for reducing the incidence of otitis media comprising administering to humans an indigestible oligosaccharide selected from the group consisting of fructooligosaccharides, fructosans, xylooligosaccharides and galactooligosaccharides. The indigestible oligosaccharides can be produced through enzymatic synthesis, chemical techniques or isolated from plant materials and are administered in the form of a nutritional product, candy, tablets, chewing gums, lozenges, milk products, yogurts and the like. In a preferred embodiment of this invention, the indigestible oligosaccharides have a DP of 2 to 20 and still more preferably are the fructooligosaccharides GF2, GF3 and GF4. | ||||||
| 134 | NUTRITIONAL FORMULATIONS CONTAINING LACTO-N-NEOTETRAOSE | EP98913279.0 | 1998-03-30 | EP0973413A1 | 2000-01-26 | PRIETO, Pedro, A.; KROENING, Terry, A. |
| A nutritional formulation containing an effective amount of Lacto-N-neoTetraose to simulate the growth and/or metabolic activity of Bifidobacterium is provided. A process of inhibiting bacterial infections caused by Bacteroides, Clostridium, and E. coli including the step of feeding the nutritional composition to a subject is also provided. | ||||||
| 135 | Non-reducing oligosaccharides and their production and use | EP94304656.5 | 1994-06-27 | EP0636632B1 | 1999-11-10 | Mandai, Takahiko; Shibuya, Takashi; Sugimoto, Toshiyuki; Miyake, Toshio |
| 136 | Enhancing and stabilizing agent of the activity of bifidus factor | EP97402327.7 | 1997-10-03 | EP0835658A3 | 1999-05-26 | Mori, Hiroharu; Kaneko, Tsutomu; Isawa, Kakuhei |
The present invention relates to an agent for enhancing and stabilizing the activity of Bifidus factor, containing at least one member selected from the group consisting of ascorbic acid, hyposulfurous acid and acetic anhydride as the effective ingredient, and by preparing the agent singly or in combination with Bifidus factor as a food and drink type or as a composition of pharmaceutical type, intestinal microflora can be ameliorated. The agent can be used as a selective medium for assaying the number of bifidobacteria. |
||||||
| 137 | USE OF INDIGESTIBLE OLIGOSACCHARIDES TO TREAT AND PREVENT OTITIS MEDIA IN HUMANS | EP96922652.0 | 1996-07-02 | EP0837686A2 | 1998-04-29 | DOHNALEK, Margaret, Ione, Halpin; OSTROM, Karin, Margaret; HILTY, Milo, Duane |
| A method is provided for reducing the incidence of otitis media in infants and young children by enterally administering indigestible oligosaccharides. More specifically, the present invention relates to a method for reducing the incidence of otitis media comprising administering to humans an indigestible oligosaccharide selected from the group consisting of fructooligosaccharides, fructosans, xylooligosaccharides and galactooligosaccharides. The indigestible oligosaccharides can be produced through enzymatic synthesis, chemical techniques or isolated from plant materials and are administered in the form of a nutritional product, candy, tablets, chewing gums, lozenges, milk products, yogurts and the like. In a preferred embodiment of this invention, the indigestible oligosaccharides have a DP of 2 to 20 and still more preferably are the fructooligosaccharides GF2, GF3 and GF4. | ||||||
| 138 | Non-reducing oligosaccharides and their production and use | EP94304656.5 | 1994-06-27 | EP0636632A3 | 1996-10-09 | Mandai, Takahiko; Shibuya, Takashi; Sugimoto, Toshiyuki; Miyake, Toshio |
Novel non-reducing oligosaccharide having a structure represented by the formula of alpha-D-oligoglucosyl alpha-D-oligoglucoside is obtained by exposing either an aqueous solution which contains trehalose and an alpha-glucosyl saccharide or an aqueous solution which contains a non-reducing saccharide bearing a trehalose structure at its end to a saccharide-transferring enzyme. The oligosaccharide has a reduced sweetness, superior stability, appropriate viscosity and less or no susceptibility to crystallization or superior solubility when in crystalline form. These features make the oligosaccharide very useful in various compositions including foods, beverages, cosmetics, pharmaceuticals and shaped bodies. |
||||||
| 139 | Method for the preparation of a substance capable of proliferating bifidobacteria growth | EP90306429.3 | 1990-06-13 | EP0404425A1 | 1990-12-27 | Masai, Teruhisa; Shibuta, Takanobu; Yoshida, Yasuyuki; Suzuki, Yohsuke |
The present invention relates to a method for purification of a bifidobacteria-proliferating substance which comprises treating the extract of soybean or its treated matters or soybean whey or treated solutions thereof with an ultrafiltration membrane, treating with activated carbon and then subjecting to an electrodialysis treatment. The present invention also relates to the thus obtained bifidobacteria-proliferating substance. |
||||||
| 140 | COMPOSITION FOR USE IN STIMULATING THE INTESTINAL FLORA IN INFANTS DELIVERED BY CAESAREAN SECTION | EP17205437.1 | 2006-10-20 | EP3326634A2 | 2018-05-30 | Boehm, Günther; Knol, Jan; Stahl, Bernd |
The present invention relates to compositions to be administered to infants delivered via caesarian section and in particular to the use of a) at least two different microorganisms; or b) at least one microorganism and at least one indigestible oligosaccharide; or c) at least two, preferably three, different Bifidobacteria species, subspecies or strains for the manufacture of a composition for enteral administration to an infant delivered via caesarean section. Thereby it is possible to stimulate the healthy development of the intestinal flora of said infants. |
||||||
